Novartis AG (NVS)
158.00
-0.86
(-0.54%)
USD |
NYSE |
Aug 24, 16:00
158.00
0.00 (0.00%)
After-Hours: 20:00
Novartis Total Liabilities (Quarterly) : 80.09B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 80.09B |
| March 31, 2026 | 79.61B |
| December 31, 2025 | 69.02B |
| September 30, 2025 | 62.54B |
| June 30, 2025 | 62.34B |
| March 31, 2025 | 61.49B |
| December 31, 2024 | 62.64B |
| September 30, 2024 | 60.08B |
| June 30, 2024 | 55.60B |
| March 31, 2024 | 54.58B |
| December 31, 2023 | 57.07B |
| September 30, 2023 | 74.45B |
| June 30, 2023 | 59.05B |
| March 31, 2023 | 60.10B |
| December 31, 2022 | 62.34B |
| September 30, 2022 | 57.57B |
| June 30, 2022 | 59.90B |
| March 31, 2022 | 63.51B |
| December 31, 2021 | 68.06B |
| September 30, 2021 | 64.27B |
| June 30, 2021 | 69.89B |
| March 31, 2021 | 71.16B |
| December 31, 2020 | 75.52B |
| September 30, 2020 | 75.12B |
| June 30, 2020 | 69.88B |
| Date | Value |
|---|---|
| March 31, 2020 | 72.12B |
| December 31, 2019 | 62.86B |
| September 30, 2019 | 63.37B |
| June 30, 2019 | 64.79B |
| March 31, 2019 | 90.64B |
| December 31, 2018 | 66.95B |
| September 30, 2018 | 64.97B |
| June 30, 2018 | 65.16B |
| March 31, 2018 | 64.31B |
| December 31, 2017 | 59.00B |
| September 30, 2017 | 62.60B |
| June 30, 2017 | 63.77B |
| March 31, 2017 | 64.34B |
| December 31, 2016 | 55.50B |
| September 30, 2016 | 58.94B |
| June 30, 2016 | 58.90B |
| March 31, 2016 | 60.56B |
| December 31, 2015 | 54.78B |
| September 30, 2015 | 56.14B |
| June 30, 2015 | 56.58B |
| March 31, 2015 | 58.49B |
| December 31, 2014 | 54.92B |
| September 30, 2014 | 53.95B |
| June 30, 2014 | 55.25B |
| March 31, 2014 | 55.00B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Roche Holding AG | -- |
| AstraZeneca PLC | 66.63B |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
| Merck & Co., Inc. | 87.82B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.03B |
| Shareholders Equity (Quarterly) | 41.54B |
| Debt to Equity Ratio | 1.180 |
| Current Ratio | 0.8615 |
| Net Debt Paydown Yield | -1.24% |